Literature DB >> 22723456

Kidney function and white matter disease in young stroke patients: analysis of the stroke in young fabry patients study population.

Robert Steinicke1, Beate Gaertner, Ulrike Grittner, Wolf Schmidt, Martin Dichgans, Peter U Heuschmann, Christian Tanislav, Jukka Putaala, Manfred Kaps, Matthias Endres, Reinhold Schmidt, Franz Fazekas, Bo Norrving, Arndt Rolfs, Peter Martus, Turgut Tatlisumak, Christian Enzinger, Gerhard Jan Jungehulsing.   

Abstract

BACKGROUND AND
PURPOSE: Impaired kidney function is thought to be associated with small vessel disease, outcome, and mortality in the general stroke population. Data are limited regarding young patients. The aim of this study was to investigate the association of kidney function and white matter hyperintensities (WMHs) in young patients with first ischemic stroke.
METHODS: We analyzed 2500 young (18-55 years) patients with first-ever ischemic stroke from the prospective observational Stroke in Young Fabry Patients (SIFAP1) study with available MRI data on WMH. Of these, 2009 had available data concerning estimated glomerular filtration rate (eGFR). Kidney function was expressed as eGFR by the Modification of Diet in Renal Disease method. Deep WMHs on MRI were classified by the Fazekas score. Multivariate analysis was performed using a regression model with random effects.
RESULTS: Mean eGFR was 96.7 mL/min in those with WMH Grade 0 to 1 (none to mild), 90.7 mL/min in WMH Grade 2 (moderate), and 89 mL/min in WMH Grade 3 (severe). Univariate analysis revealed WMH to be associated with age (P<0.001), hypertension (P<0.001), cardiovascular disease (P=0.015), overweight (body mass index >25 kg/m(2); P=0.013), current smoking (P=0.044), and eGFR (P=0.009). In multivariate analysis, age, hypertension, and eGFR remained associated with WMH severity.
CONCLUSIONS: In young patients with acute ischemic stroke, lower eGFR values in the normal range are associated with the presence of moderate to severe WMH. Clinical Trial Registration- URL: http://clinicaltrials.gov. Unique Identifier: NCT00414583.

Entities:  

Mesh:

Year:  2012        PMID: 22723456     DOI: 10.1161/STROKEAHA.111.645713

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  9 in total

Review 1.  Stroke and Chronic Kidney Disease: Epidemiology, Pathogenesis, and Management Across Kidney Disease Stages.

Authors:  Taimur Dad; Daniel E Weiner
Journal:  Semin Nephrol       Date:  2015-07       Impact factor: 5.299

2.  White matter hyperintensity in ischemic stroke patients: it may regress over time.

Authors:  A-Hyun Cho; Hyeong-Ryul Kim; Woojun Kim; Dong Won Yang
Journal:  J Stroke       Date:  2015-01-30       Impact factor: 6.967

3.  Association Between White Matter Hyperintensities and Chronic Kidney Disease: A Systematic Review and Meta-Analysis.

Authors:  Cun-Sheng Wei; Cai-Yun Yan; Xiao-Rong Yu; Lin Wang; Rui Zhang; Jun-Ying Jiang; Qi Dai; Jun-Rong Li; Xue Mei Chen
Journal:  Front Med (Lausanne)       Date:  2022-05-03

Review 4.  Fabry Disease: Recognition, Diagnosis, and Treatment of Neurological Features.

Authors:  Michela Ranieri; Gloria Bedini; Eugenio Agostino Parati; Anna Bersano
Journal:  Curr Treat Options Neurol       Date:  2016-07       Impact factor: 3.598

Review 5.  Biomarkers and Imaging Findings of Anderson-Fabry Disease-What We Know Now.

Authors:  Idalina Beirão; Ana Cabrita; Márcia Torres; Fernando Silva; Patrício Aguiar; Francisco Laranjeira; Ana Marta Gomes
Journal:  Diseases       Date:  2017-06-11

6.  Glomerular hyperfiltration is associated with dementia: A nationwide population-based study.

Authors:  Min Woo Kang; Sehoon Park; Soojin Lee; Yeonhee Lee; Semin Cho; Kyungdo Han; Hanna Cho; Yaerim Kim; Yong Chul Kim; Seung Seok Han; Hajeong Lee; Jung Pyo Lee; Kwon Wook Joo; Chun Soo Lim; Yon Su Kim; Dong Ki Kim
Journal:  PLoS One       Date:  2020-01-28       Impact factor: 3.240

7.  Evaluation of influence of chronic kidney disease and sodium disturbances on clinical course of acute and sub-acute stage first-ever ischemic stroke.

Authors:  Anetta Lasek-Bal; Michał Holecki; Bartłomiej Kret; Anna Hawrot-Kawecka; Jan Duława
Journal:  Med Sci Monit       Date:  2014-08-07

8.  Enzyme replacement therapy and white matter hyperintensity progression in Fabry disease.

Authors:  James D Stefaniak; Laura M Parkes; Adrian R Parry-Jones; Gillian M Potter; Andy Vail; Ana Jovanovic; Craig J Smith
Journal:  Neurology       Date:  2018-09-12       Impact factor: 9.910

9.  Early renal dysfunction and fibroblast growth factor-23 in patients with small vessel disease-related stroke.

Authors:  Simon Fandler-Höfler; Christian Enzinger; Markus Kneihsl; Daniela Pinter; Sebastian Eppinger; Barbara Obermayer-Pietsch; Anna Goritschan; Hildegard Hafner-Giessauf; Alexander R Rosenkranz; Franz Fazekas; Thomas Gattringer
Journal:  Sci Rep       Date:  2019-10-28       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.